Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM
Phase 4
Completed
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT00789139
- Lead Sponsor
- Dr Ange FERRACCI
- Brief Summary
Post Marketing study, Interventional, Prospective, non randomised
Describe how the MD is using the information of the ICM in addition of standard FU(clinical exam and holter 24h)post AF ablation(1 year FU).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
Inclusion Criteria
- AF thermoablation indication
- Informed Consent signed,
- Age between 18 & 75
Exclusion Criteria
- Participation to other clinical trial
- Non compliant patient
- Pregnant women
- Left Atrial thrombus
- Endocarditis, infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Clinical exam and ECG record one month, 3 months, 6 months , 12 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie arrhythmia recurrence after pulmonary vein isolation in AF patients monitored with ICM?
How does ICM-based monitoring compare to standard 24h Holter and clinical exams in detecting post-ablation AF recurrence?
Which biomarkers are associated with AF recurrence risk in patients undergoing pulmonary vein isolation with ICM surveillance?
What adverse events are reported in ICM implantation for long-term AF monitoring compared to traditional methods?
How effective is ICM in guiding antiarrhythmic drug adjustments versus standard follow-up after AF ablation?
Trial Locations
- Locations (1)
Saint Joseph Hospital
🇫🇷Marseille, France
Saint Joseph Hospital🇫🇷Marseille, France